iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis

Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the treatment of endometriosis (EM), which is the most common gynecological disease. Targeted delivery of siRNA therapeutics is a prerequisite for successful treatment without adverse effects. Here we evaluated the RGD1-...

Descripción completa

Detalles Bibliográficos
Autores principales: Egorova, Anna, Petrosyan, Mariya, Maretina, Marianna, Bazian, Elena, Krylova, Iuliia, Baranov, Vladislav, Kiselev, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459007/
https://www.ncbi.nlm.nih.gov/pubmed/37631322
http://dx.doi.org/10.3390/pharmaceutics15082108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459007/
https://www.ncbi.nlm.nih.gov/pubmed/37631322
http://dx.doi.org/10.3390/pharmaceutics15082108

Ejemplares similares